Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 257.65
-3.00 (-1.15%)
At close: Jan 20, 2026
Chandan Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 2,555 | 2,301 | 1,766 | 1,369 | 1,196 | 871.63 |
Other Revenue | 12.48 | 12.48 | 0.91 | - | - | 0 |
| 2,567 | 2,314 | 1,767 | 1,369 | 1,196 | 871.63 | |
Revenue Growth (YoY) | - | 30.95% | 29.07% | 14.49% | 37.17% | - |
Cost of Revenue | 1,278 | 1,105 | 826.12 | 666.72 | 634.11 | 401.04 |
Gross Profit | 1,289 | 1,208 | 940.69 | 702.18 | 561.53 | 470.59 |
Selling, General & Admin | 471.36 | 461.65 | 412.81 | 294.16 | 219.87 | 162.25 |
Other Operating Expenses | 307.73 | 320.86 | 263.02 | 314.22 | 319.12 | 258.27 |
Operating Expenses | 863.46 | 849.95 | 709.87 | 629.27 | 558.59 | 436.11 |
Operating Income | 425.99 | 358.36 | 230.82 | 72.91 | 2.94 | 34.48 |
Interest Expense | -46.57 | -40.53 | -24.81 | -18.02 | -15.99 | -18.95 |
Interest & Investment Income | 7.3 | 7.3 | 10.64 | 0.8 | 1.46 | 0.12 |
Other Non Operating Income (Expenses) | 2.56 | -4.48 | -2.05 | -5.58 | 0.99 | 0.97 |
Pretax Income | 389.29 | 320.65 | 214.61 | 50.11 | -10.6 | 16.62 |
Income Tax Expense | 101.94 | 85.49 | 51.05 | 14.25 | 0.32 | 7.76 |
Earnings From Continuing Operations | 287.35 | 235.16 | 163.56 | 35.86 | -10.93 | 8.86 |
Minority Interest in Earnings | -16.05 | -13.44 | -0.79 | -2.18 | -0.16 | - |
Net Income | 271.3 | 221.71 | 162.77 | 33.68 | -11.09 | 8.86 |
Net Income to Common | 271.3 | 221.71 | 162.77 | 33.68 | -11.09 | 8.86 |
Net Income Growth | - | 36.21% | 383.29% | - | - | - |
Shares Outstanding (Basic) | 23 | 21 | 20 | 20 | 20 | - |
Shares Outstanding (Diluted) | 23 | 21 | 20 | 20 | 20 | - |
Shares Change (YoY) | 9.34% | 2.86% | - | - | - | - |
EPS (Basic) | 12.05 | 10.78 | 8.14 | 1.68 | -0.55 | - |
EPS (Diluted) | 12.05 | 10.78 | 8.14 | 1.68 | -0.55 | - |
EPS Growth | - | 32.42% | 384.44% | - | - | - |
Free Cash Flow | - | -677.58 | -184.25 | -7.82 | -5.42 | - |
Free Cash Flow Per Share | - | -32.94 | -9.21 | -0.39 | -0.27 | - |
Dividend Per Share | - | - | 1.500 | 1.000 | 0.500 | - |
Dividend Growth | - | - | 50.00% | 100.00% | - | - |
Gross Margin | 50.23% | 52.23% | 53.24% | 51.30% | 46.97% | 53.99% |
Operating Margin | 16.59% | 15.49% | 13.06% | 5.33% | 0.25% | 3.96% |
Profit Margin | 10.57% | 9.58% | 9.21% | 2.46% | -0.93% | 1.02% |
Free Cash Flow Margin | - | -29.29% | -10.43% | -0.57% | -0.45% | - |
EBITDA | 525.71 | 425.81 | 264.86 | 93.8 | 22.54 | 50.07 |
EBITDA Margin | 20.48% | 18.40% | 14.99% | 6.85% | 1.88% | 5.75% |
D&A For EBITDA | 99.72 | 67.45 | 34.04 | 20.9 | 19.61 | 15.59 |
EBIT | 425.99 | 358.36 | 230.82 | 72.91 | 2.94 | 34.48 |
EBIT Margin | 16.59% | 15.49% | 13.06% | 5.33% | 0.25% | 3.96% |
Effective Tax Rate | 26.19% | 26.66% | 23.79% | 28.43% | - | 46.68% |
Revenue as Reported | 2,582 | 2,322 | 1,778 | 1,370 | 1,199 | 873.97 |
Advertising Expenses | - | - | - | - | - | 0.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.